Sandrine Ferrand

445 total citations
10 papers, 248 citations indexed

About

Sandrine Ferrand is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Sandrine Ferrand has authored 10 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Oncology. Recurrent topics in Sandrine Ferrand's work include Neuroblastoma Research and Treatments (4 papers), Cancer therapeutics and mechanisms (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Sandrine Ferrand is often cited by papers focused on Neuroblastoma Research and Treatments (4 papers), Cancer therapeutics and mechanisms (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Sandrine Ferrand collaborates with scholars based in Switzerland, United States and France. Sandrine Ferrand's co-authors include J. Fraser Glickman, Isabelle Janoueix‐Lerosey, Gudrun Schleiermacher, Valérie Combaret, Gaëlle Pierron, Olivier Delattre, Emmanuel Barillot, Stéphanie Jouannet, Caroline Louis‐Brennetot and Romain Daveau and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Alzheimer s Disease.

In The Last Decade

Sandrine Ferrand

10 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandrine Ferrand Switzerland	8	163	84	41	39	25	10	248
Jonas P. Becker Germany	7	151 0.9×	67 0.8×	18 0.4×	64 1.6×	15 0.6×	10	268
Derek J. Hoelz United States	9	278 1.7×	39 0.5×	60 1.5×	93 2.4×	9 0.4×	15	387
Adam L. Garske United States	9	472 2.9×	24 0.3×	18 0.4×	70 1.8×	43 1.7×	9	592
Robert Gustafsson Sweden	8	228 1.4×	40 0.5×	54 1.3×	24 0.6×	6 0.2×	12	327
Tatjana Starzetz Germany	6	150 0.9×	61 0.7×	37 0.9×	45 1.2×	163 6.5×	9	342
Biqing Zhu China	12	200 1.2×	37 0.4×	72 1.8×	55 1.4×	23 0.9×	31	362
Merav D. Shmueli Israel	11	227 1.4×	14 0.2×	22 0.5×	73 1.9×	11 0.4×	15	329
Elena Delgado Spain	6	182 1.1×	16 0.2×	17 0.4×	105 2.7×	11 0.4×	7	438
C Reilly United States	6	160 1.0×	36 0.4×	16 0.4×	89 2.3×	139 5.6×	6	310

Countries citing papers authored by Sandrine Ferrand

Since Specialization

Citations

This map shows the geographic impact of Sandrine Ferrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Ferrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Ferrand more than expected).

Fields of papers citing papers by Sandrine Ferrand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrine Ferrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Ferrand. The network helps show where Sandrine Ferrand may publish in the future.

Co-authorship network of co-authors of Sandrine Ferrand

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Ferrand. A scholar is included among the top collaborators of Sandrine Ferrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Ferrand. Sandrine Ferrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Groot‐Kormelink, Paul J., Sandrine Ferrand, Nicholas Kelley, et al.. (2016). High Throughput Random Mutagenesis and Single Molecule Real Time Sequencing of the Muscle Nicotinic Acetylcholine Receptor. PLoS ONE. 11(9). e0163129–e0163129. 4 indexed citations

Guimier, Anne, Sandrine Ferrand, Gaëlle Pierron, et al.. (2014). Clinical Characteristics and Outcome of Patients with Neuroblastoma Presenting Genomic Amplification of Loci Other than MYCN. PLoS ONE. 9(7). e101990–e101990. 15 indexed citations

Boeva, Valentina, Stéphanie Jouannet, Romain Daveau, et al.. (2013). Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis. PLoS ONE. 8(8). e72182–e72182. 28 indexed citations

Cazes, Alex, Caroline Louis‐Brennetot, Pierre Mazot, et al.. (2012). Characterization of Rearrangements Involving the ALK Gene Reveals a Novel Truncated Form Associated with Tumor Aggressiveness in Neuroblastoma. Cancer Research. 73(1). 195–204. 44 indexed citations

Ferrand, Sandrine, et al.. (2011). Screening for Mevalonate Biosynthetic Pathway Inhibitors Using Sensitized Bacterial Strains. SLAS DISCOVERY. 16(6). 637–646. 9 indexed citations

Bourdeaut, Franck, Sandrine Ferrand, Laurence Brugières, et al.. (2011). ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome. European Journal of Human Genetics. 20(3). 291–297. 32 indexed citations

Schopfer, Ulrich, et al.. (2009). Hypothesis-Driven Screening. Methods in molecular biology. 575. 297–316. 2 indexed citations

Glickman, J. Fraser, et al.. (2008). Scintillation Proximity Assays in High-Throughput Screening. Assay and Drug Development Technologies. 6(3). 433–455. 85 indexed citations

Hübinger, Gabriele, Sandra Gordon, Rafael Fracasso, et al.. (2008). Inhibition of PHF-like Tau Hyperphosphorylation in SH-SY5Y Cells and Rat Brain Slices by K252a. Journal of Alzheimer s Disease. 13(3). 281–294. 10 indexed citations

10.

Ferrand, Sandrine, et al.. (2005). Statistical Evaluation of a Self-Deconvoluting Matrix Strategy for High-Throughput Screening of the CXCR3 Receptor. Assay and Drug Development Technologies. 3(4). 413–424. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact